Breast Cancer Gene: Why Most Women Can't Do What Jolie Did
When it comes to breast cancer, your health care can be trumped by your finances: Even if your best bet is to follow in Angelia Jolie's footsteps, you may not be able to.
breast cancer
Petition to Victoria's Secret: Make Bras for Breast Cancer Survivors
A petition on Change.org calling on Victoria's Secret to create a special line of "Survivor" bras for breast cancer survivors who have undergone mastectomies is going viral.
Breast Cancer's Financial Toll: Where to Go for Help
A breast cancer diagnosis can be like an earthquake in the life of the patient and her family, but the medical community is there to help guide them. What's often hard to find is a monetary lifeline for those in danger of getting washed away by the financial tidal wave that can follow.
Breast Cancer's Financial Toll: Your Money or Your Life
Breast cancer is the second most common cancer among American women: 12% will develop it at some point in their lives, and at that point, the health battle begins. But those women often must fight one a second front as well, dealing with the multiple threats cancer poses to their financial well-being.
Perfume to Benefit Breast Cancer May Also Cause Cancer
The Susan G. Komen Foundation's partnerships bring in millions each year for breast cancer research. But one of its partners has brought it an ironic problem: The perfume Promise Me, marketed to benefit the charity, contains a hormone disruptor that studies point to as a contributing cause of breast cancer.
Another Cancer-Drug Failure Highlights Difficulties Facing Pharmas
Sanofi-Aventis announced its cancer drug candidate iniparib failed in a late-stage clinical trial. Other pharmaceutical companies have also experienced recent setbacks as they scramble to bolster their pipelines ahead of the patent cliff, when they will be forced to compete with cheaper generics.
Wyeth Loses Appeal Over Hormone Replacement Drugs
Wyeth Pharmecuticals on Wednesday lost its appeal of a decision that awarded $58 million in damages to three women who claimed the company's hormone-replacement drugs caused their breast cancer. The news could bode badly for the Pfizer-owned company, which has thousands of such cases pending.
Setback for Roche and Immunogen Breast Cancer Drug
The FDA denied accelerated approval of Roche's trastuzumab-DM1 (T-DM1) license application. T-DM1 is a potential breast cancer treatment. Roche will continue with its trials and plans a global regulatory submission in mid-2012.
Will FDA Withdraw Avastin Approval for Breast Cancer?
Roche's blockbuster cancer drug, Avastin, could lose its U.S. Food and Drug Administration approval for use against breast cancer after an FDA panel recommended the withdrawal. Studies failed to show the drug extends breast-cancer patients' lives, panelists say.
Industry Attacks Study Linking Breast Cancer and Cleaning Products
A study published Tuesday suggests that use of cleaning products contributes to increased breast cancer risk. If you were hoping this study could give you reasons to clean less, even the study authors note the evidence is far from conclusive.
A Judge Rules: 'You Can't Patent Nature'
District Judge Robert Sweet has invalidated patents Myriad Genetics holds on naturally occurring snippets of human DNA. At issue are genetic tests for breast and ovarian cancer, but the ruling could upend the whole biotech industry -- if it survives appeals.
Breast Cancer Screening: Why Can't Experts Agree?
A new study finds that screening women for breast cancer failed to significantly reduce deaths in Danish women. This contrasts with earlier results, including a 25% drop in breast cancer mortality in Copenhagen after mammography screening was introduced.
